Best in Biotech 28 Nov 2024 Six antisense oligonucleotide companies shaping the future of genetic medicine …candidate, which recently became the first-ever RNA editing candidate to be tested in clinical trials, Wave Life Sciences also has an antisense oligonucleotide candidate called WVE-003 being tested in a… November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 23 Dec 2022 Merck and Kelun-Biotech collaborating on seven ADC cancer candidates …seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent… December 23, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2020 MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience …is developing vaccine candidates for a number of infectious diseases such as Lassa fever. It also has some immuno-oncology therapies in preclinical development. Themis’ most advanced candidate is a vaccine… May 28, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry …primary focus is on hormone-driven cancers, including breast, ovarian, and endometrial cancers. Context’s lead product candidate, CTIM-76, is a selective Claudin 6 (CLDN6) x CD3 bispecific antibody designed to target… May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Oct 2020 Top 10 Companies Combining AI and Drug Discovery in Europe …Location: Oxford, UK Founded: 2012 Exscientia was one of the first companies to apply AI technology to drug discovery. Its focus is to quickly identify and optimize drug candidates that… October 19, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates …or the other – Diakonos’ candidate double loads tumor antigens with both lysate and mRNA, in a design that more closely mimics a viral infection. According to Hartenbach, this approach… February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2016 New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira …Figure 1. Psoriasis can appear in multiple parts of the body and cause intense pain. The new candidate, guselkumab, is a fully human monoclonal antibody against interleukin-23 that is delivered… October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2017 FREE TICKET Giveaway – European Antibody Congress Our wonderful readers now have the chance to win a FREE ticket for the European Antibody Congress in Basel, Switzerland! On 31st October – 2nd November you will have the… September 5, 2017 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2020 Kymab Wins UK Supreme Court Antibody Battle Against Regeneron The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for… June 30, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jan 2018 Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors. Innate Pharma uses antibodies to enhance the immune… January 30, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 25 Sep 2017 Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains …powerful ‘tri-specific antibody’. Structure of the HIV virus. Sanofi’s tri-antibody treatment targets the synthesis of the phospholipid envelope. Current treatments are based on the use of antiretroviral therapy (ART), which… September 25, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2022 Scancell signs agreement with Genmab …commercialize a Scancell investigational anti-glycan monoclonal antibody into novel therapeutic products. Genmab has been granted the exclusive right to develop and commercialize the Scancell antibody in multiple novel potential therapeutic… October 26, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email